IDA
ELV icon

Intelligence Driven Advisers’s Elevance Health ELV Stock Holding History

Intelligence Driven Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
618
-91
-13% -$33.7K 0.04% 119
2026
Q1 		$208K Buy
+709
New +$233K 0.04% 118
2025
Q2 		– Sell
-526
Closed -$229K – 122
2025
Q1 		$229K Sell
526
-266
-34% -$107K 0.04% 86
2024
Q4 		$292K Sell
792
-387
-33% -$162K 0.06% 75
2024
Q3 		$613K Buy
1,179
+71
+6% +$37.9K 0.09% 59
2024
Q2 		$600K Buy
1,108
+508
+85% +$269K 0.09% 61
2024
Q1 		$311K Buy
+600
New +$298K 0.05% 73
2023
Q2 		– Sell
-494
Closed -$239K – 97
2023
Q1 		$239K Buy
494
+23
+5% +$10.9K 0.04% 79
2022
Q4 		$224K Sell
471
-6
-1% -$3.05K 0.04% 91
2022
Q3 		$228K Buy
+477
New +$228K 0.05% 99

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Intelligence Driven Advisers's ELV Position: Q2 2026 in Review

Intelligence Driven Advisers reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $33.7K and leaving 618 shares worth $239K. The position accounts for 0.04% of the portfolio, ranked #119.

Intelligence Driven Advisers first reported a position in ELV in Q3 2022 and has held it in 10 quarters since. The position peaked at $613K in Q3 2024. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Intelligence Driven Advisers held 618 shares of Elevance Health worth $239K as of Q2 2026.
  • Intelligence Driven Advisers sold 91 Elevance Health shares in Q2 2026, an estimated $33.7K.
  • Elevance Health made up 0.04% of Intelligence Driven Advisers's portfolio in Q2 2026, its #119 holding.
  • Intelligence Driven Advisers first reported a position in Elevance Health in Q3 2022 and has held it in 10 quarters since.
  • Intelligence Driven Advisers's Elevance Health position peaked at $613K in Q3 2024.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Intelligence Driven Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.